- Home
- HQI vs ONCY Comparison
HQI vs ONCY Comparison
Compare HQI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HQI | ONCY |
|---|---|---|
| Founded | 2002 | 1998 |
| Country | United States | Canada |
| Employees | 65000 | N/A |
| Industry | Professional Services | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.8M | 94.0M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | HQI | ONCY |
|---|---|---|
| Price | $10.83 | $1.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $13.00 | $6.00 |
| AVG Volume (30 Days) | 46.9K | ★ 706.5K |
| Earning Date | 11-06-2025 | 03-06-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ 412.84 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $31,691,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.06 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.38 | $0.33 |
| 52 Week High | $15.75 | $1.51 |
Technical Indicators
Market Signals| Indicator | HQI | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 64.20 | 55.52 |
| Support Level | $10.33 | $0.96 |
| Resistance Level | $11.47 | $1.07 |
| Average True Range (ATR) | 0.61 | 0.07 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 50.76 | 81.63 |
Price Performance
Historical ComparisonAbout HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.